Novacyt Sa Stock Price Prediction

NVYTF Stock  USD 0.70  0.13  22.81%   
As of 18th of December 2024 the relative strength index (rsi) of Novacyt SA's share price is below 20 . This indicates that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Oversold Vs Overbought

0

 
Oversold
 
Overbought
The successful prediction of Novacyt SA's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Novacyt SA and does not consider all of the tangible or intangible factors available from Novacyt SA's fundamental data. We analyze noise-free headlines and recent hype associated with Novacyt SA, which may create opportunities for some arbitrage if properly timed.
Using Novacyt SA hype-based prediction, you can estimate the value of Novacyt SA from the perspective of Novacyt SA response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Novacyt SA to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Novacyt because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Novacyt SA after-hype prediction price

    
  USD 0.7  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Novacyt SA Basic Forecasting Models to cross-verify your projections.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Novacyt SA's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.030.625.13
Details
Naive
Forecast
LowNextHigh
0.020.835.34
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.700.700.70
Details

Novacyt SA After-Hype Price Prediction Density Analysis

As far as predicting the price of Novacyt SA at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Novacyt SA or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Novacyt SA, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Novacyt SA Estimiated After-Hype Price Volatility

In the context of predicting Novacyt SA's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Novacyt SA's historical news coverage. Novacyt SA's after-hype downside and upside margins for the prediction period are 0.03 and 5.21, respectively. We have considered Novacyt SA's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.70
0.70
After-hype Price
5.21
Upside
Novacyt SA is abnormally volatile at this time. Analysis and calculation of next after-hype price of Novacyt SA is based on 3 months time horizon.

Novacyt SA Pink Sheet Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Novacyt SA is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Novacyt SA backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Novacyt SA, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.39 
4.51
 0.00  
  0.01 
0 Events / Month
8 Events / Month
Uncertain
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.70
0.70
0.00 
0.00  
Notes

Novacyt SA Hype Timeline

Novacyt SA is now traded for 0.70. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.01. Novacyt is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is now at -0.39%. %. The volatility of related hype on Novacyt SA is about 12169.84%, with the expected price after the next announcement by competition of 0.69. The company has price-to-book ratio of 0.4. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Novacyt SA recorded a loss per share of 0.17. The entity had not issued any dividends in recent years. The firm had 15:1 split on the 28th of June 2012. Assuming the 90 days horizon the next anticipated press release will be uncertain.
Check out Novacyt SA Basic Forecasting Models to cross-verify your projections.

Novacyt SA Related Hype Analysis

Having access to credible news sources related to Novacyt SA's direct competition is more important than ever and may enhance your ability to predict Novacyt SA's future price movements. Getting to know how Novacyt SA's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Novacyt SA may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
AEMDAethlon Medical 0.03 7 per month 3.12 (0.02) 7.50 (6.98) 25.97 
RWLKRewalk Robotics 0.00 0 per month 1.97  0.04  5.26 (3.33) 21.49 
BBLGBone Biologics Corp(0.07)3 per month 6.56  0.08  18.13 (9.77) 163.17 
TIVCTivic Health Systems(0.01)5 per month 5.02 (0.0008) 12.12 (7.69) 79.31 
TLISTalis Biomedical Corp 0.00 0 per month 0.00 (0.19) 5.32 (10.69) 68.77 
VIVEViveve Medical 0.00 0 per month 0.00 (0.07) 20.00 (27.27) 120.93 
CTSOCytosorbents Crp(0.15)9 per month 0.00 (0.08) 9.15 (10.00) 35.58 
IINNInspira Technologies Oxy(0.04)3 per month 0.00 (0.12) 5.34 (4.46) 15.46 
BWAYBrainsway 0.36 9 per month 2.74  0.06  5.42 (4.30) 24.68 
RPIDRapid Micro Biosystems(0.02)6 per month 2.86  0.1  6.00 (4.76) 24.78 
HSCSHeart Test Laboratories 0.12 1 per month 4.90  0.07  11.44 (7.84) 58.33 
MYOMyomo Inc 0.72 8 per month 2.48  0.15  6.04 (4.30) 25.51 
OPGNOpGen Inc 0.00 0 per month 0.00 (0.14) 7.05 (12.02) 39.12 
BMRABiomerica 0.02 4 per month 5.24  0.03  9.38 (6.67) 41.32 
BIOLBIOLASE 0.01 7 per month 0.00 (0.11) 18.75 (15.79) 64.92 
SMLRSemler Scientific(1.57)9 per month 4.12  0.23  16.06 (7.65) 44.97 
NAOVNanoVibronix(0.03)4 per month 0.00 (0.01) 8.77 (8.47) 27.74 

Novacyt SA Additional Predictive Modules

Most predictive techniques to examine Novacyt price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Novacyt using various technical indicators. When you analyze Novacyt charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Novacyt SA Predictive Indicators

The successful prediction of Novacyt SA stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Novacyt SA, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Novacyt SA based on analysis of Novacyt SA hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Novacyt SA's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Novacyt SA's related companies.

Story Coverage note for Novacyt SA

The number of cover stories for Novacyt SA depends on current market conditions and Novacyt SA's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Novacyt SA is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Novacyt SA's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Novacyt SA Short Properties

Novacyt SA's future price predictability will typically decrease when Novacyt SA's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Novacyt SA often depends not only on the future outlook of the potential Novacyt SA's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Novacyt SA's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding70.6 M

Complementary Tools for Novacyt Pink Sheet analysis

When running Novacyt SA's price analysis, check to measure Novacyt SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novacyt SA is operating at the current time. Most of Novacyt SA's value examination focuses on studying past and present price action to predict the probability of Novacyt SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novacyt SA's price. Additionally, you may evaluate how the addition of Novacyt SA to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Volatility Analysis
Get historical volatility and risk analysis based on latest market data